{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:05:58Z","timestamp":1792569958660,"version":"4.5.0"},"reference-count":31,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:p content-type=\"fine-print\"><jats:italic>Object.<\/jats:italic> Convection-enhanced delivery (CED) can be used safely to perfuse regions of the central nervous system (CNS) with therapeutic agents in a manner that bypasses the blood\u2014brain barrier (BBB). These features make CED a potentially ideal method for the distribution of potent chemotherapeutic agents with certain pharmacokinetic properties to tumors of the CNS. To determine the safety and efficacy of the CED of two chemotherapeutic agents (with properties ideal for this method of delivery) into the CNS, the authors perfused naive rats and those harboring 9L gliomas with carboplatin or gemcitabine.<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Methods.<\/jats:italic> Dose-escalation toxicity studies were performed by perfusing the striatum (10 \u00b5l, 24 rats) and brainstem (10 \u00b5l, 16 rats) of naive rats with carboplatin (0.1, 1, and 10 mg\/ml) or gemcitabine (0.4, 4, and 40 mg\/ml) via CED. Efficacy trials involved the intracranial implantation of 9L tumor cells in 20 Fischer 344 rats. The tumor and surrounding regions were perfused with 40 \u00b5l of saline (control group, four rats), 1 mg\/ml of carboplatin (four rats), or 4 mg\/ml of gemcitabine (four rats) 7 days after implantation. Eight rats harboring the 9L glioma were treated with the systemic administration of 60 mg\/kg of carboplatin (four rats) or 150 mg\/kg of gemcitabine (four rats) 7 days postimplantation. Clinical, gross, and histological analyses were used to determine toxicity and efficacy.<\/jats:p>\n<jats:p content-type=\"fine-print\">Toxicity occurred in rats that had received only the highest dose of the CED of carboplatin or gemcitabine. Among rats with 9L gliomas, all control and systemically treated animals died within 26 days of tumor implantation. Long-term survival (120 days) and eradication of the tumor occurred in both CED-treated groups (75% of rats in the carboplatin group and 50% of rats in the gemcitabine group). Furthermore, animals harboring the 9L glioma and treated with intratumoral CED of carboplatin or gemcitabine survived significantly longer than controls treated with intratumoral saline (p &lt; 0.01) or systemic chemotherapy (p &lt; 0.01).<\/jats:p>\n<jats:p content-type=\"fine-print\"><jats:italic>Conclusions.<\/jats:italic> The perfusion of sensitive regions of the rat brain can be accomplished without toxicity by using therapeutic concentrations of carboplatin or gemcitabine. In addition, CED of carboplatin or gemcitabine to tumors in this glioma model is safe and has potent antitumor effects. These findings indicate that similar treatment paradigms may be useful in the treatment of glial neoplasms in humans.<\/jats:p>","DOI":"10.3171\/jns.2003.99.5.0893","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T17:48:25Z","timestamp":1242236905000},"page":"893-898","source":"Crossref","is-referenced-by-count":118,"title":["Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats"],"prefix":"10.3171","volume":"99","author":[{"given":"Jeffrey W.","family":"Degen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Walbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"Vortmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Oldfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neurooncol","first-page":"91","article-title":"Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.","volume":"36","author":"Barth","year":"1998"},{"key":"b2","series-title":"Proc Natl Acad Sci USA","first-page":"2076","article-title":"Convection-enhanced delivery of macromolecules in the brain.","volume":"91","author":"Bobo","year":"1994"},{"key":"b3","series-title":"Lancet","first-page":"1008","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.","volume":"345","author":"Brem","year":"1995"},{"key":"b4","series-title":"Neurosurgery","first-page":"1391","article-title":"Comment on Kaiser MG, Parsa AT, Fine RL, et al: Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.","volume":"47","author":"Broaddus","year":"2000"},{"key":"b5","series-title":"Neurosurgery","first-page":"683","article-title":"Intracerebral clysis in a rat glioma model.","volume":"46","author":"Bruce","year":"2000"},{"key":"b6","series-title":"J Neurosurg","first-page":"315","article-title":"Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time.","volume":"90","author":"Chen","year":"1999"},{"key":"b7","series-title":"Culture of Animal Cells: A Manual of Basic Technique","author":"Freshney","year":"2000"},{"key":"b8","series-title":"Ann Oncol","first-page":"315","article-title":"NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).","volume":"11","author":"Gertler","year":"2000"},{"key":"b9","series-title":"Neuro-oncol","first-page":"45","article-title":"The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.","volume":"2","author":"Groothuis","year":"2000"},{"key":"b10","series-title":"Clin Cancer Res","first-page":"4148","article-title":"Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.","volume":"6","author":"Heimberger","year":"2000"},{"key":"b11","series-title":"Neurosurgery","first-page":"1391","article-title":"Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.","volume":"47","author":"Kaiser","year":"2000"},{"key":"b12","series-title":"J Neurosurg","first-page":"586","article-title":"Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging.","volume":"87","author":"Laske","year":"1997"},{"key":"b13","series-title":"Nat Med","first-page":"1362","article-title":"Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.","volume":"3","author":"Laske","year":"1997"},{"key":"b14","series-title":"J Neurosurg","first-page":"1021","article-title":"Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.","volume":"82","author":"Lieberman","year":"1995"},{"key":"b15","series-title":"J Neurosurg","first-page":"294","article-title":"Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates.","volume":"91","author":"Lonser","year":"1999"},{"key":"b16","series-title":"J Neurosurg","first-page":"905","article-title":"Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.","volume":"97","author":"Lonser","year":"2002"},{"key":"b17","series-title":"Cancer Res","first-page":"4971","article-title":"Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging.","volume":"61","author":"Mardor","year":"2001"},{"key":"b18","series-title":"Am J Physiol","first-page":"R292","article-title":"High-flow microinfusion: tissue penetration and pharmacodynamics.","volume":"266","author":"Morrison","year":"1994"},{"key":"b19","series-title":"J Neurosurg","first-page":"584","article-title":"Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging.","volume":"98","author":"Nguyen","year":"2003"},{"key":"b20","series-title":"Neurosurgery","first-page":"993","article-title":"Limitations of the C6\/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.","volume":"47","author":"Parsa","year":"2000"},{"key":"b21","series-title":"The Chemotherapy Source Book","year":"2001"},{"key":"b22","series-title":"J Neurosurg","first-page":"228","article-title":"Stereotaxic implantation of dispersed cell suspensions into brain. A systematic appraisal of cell placement and survival.","volume":"69","author":"Plunkett","year":"1988"},{"key":"b23","series-title":"Anticancer Drugs","first-page":"7","article-title":"Preclinical characteristics of gemcitabine.","volume":"6","author":"Plunkett","year":"1995"},{"key":"b24","series-title":"Lab Anim Sci","first-page":"269","article-title":"Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns.","volume":"41","author":"Redgate","year":"1991"},{"key":"b25","series-title":"Eur J Pharmacol","first-page":"301","article-title":"Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone.","volume":"365","author":"Rieger","year":"1999"},{"key":"b26","series-title":"Neurooncol","first-page":"109","article-title":"A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.","volume":"4","author":"Robins","year":"2002"},{"key":"b27","series-title":"J Neurosurg","first-page":"885","article-title":"Convection-enhanced delivery into the rat brainstem.","volume":"96","author":"Sandberg","year":"2002"},{"key":"b28","series-title":"J Pharmacol Exp Ther","first-page":"1647","article-title":"Distribution of 1, 3-bis(2chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.","volume":"275","author":"Strasser","year":"1995"},{"key":"b29","series-title":"Interactive LogKow (KowWin) Demo."},{"key":"b30","series-title":"J Neurol","first-page":"183","article-title":"The 9L rat brain tumor: description and application of an animal model.","volume":"224","author":"Weizsaecker","year":"1981"},{"key":"b31","series-title":"J Cancer Res Clin Oncol","first-page":"481","article-title":"Chemosensitivity of glioma cells in vitro: a meta analysis.","volume":"125","author":"Wolff","year":"1999"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/99\/5\/article-p893.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/99\/5\/article-p893.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/99\/5\/article-p893.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T23:28:01Z","timestamp":1679268481000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/99\/5\/article-p893.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":31,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/jns.2003.99.5.0893","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}